BioCryst Pharmaceuticals Inc BCRX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 12:49 PM EST
11.35quote price arrow up+0.20 (+1.79%)
Volume
2,605,385
52 week range
1.58 - 12.90

...

Loading . . .

KEY STATS

  • Open11.26
  • Day High11.66
  • Day Low11.06
  • Prev Close11.15
  • 52 Week High12.90
  • 52 Week High Date02/02/21
  • 52 Week Low1.58
  • 52 Week Low Date03/18/20
  • Market Cap2.011B
  • Shares Out177.18M
  • 10 Day Average Volume6.60M
  • Dividend-
  • Dividend Yield-
  • Beta2.69
  • 1 Year % Change176.16

RATIOS/PROFITABILITY

  • EPS (TTM)-1.09
  • P/E (TTM)-10.45
  • Fwd P/E (NTM)-10.93
  • EBITDA (MRQ)-174.009M
  • ROE (MRQ)-1,925.37%
  • Revenue (MRQ)17.81M
  • Gross Margin (MRQ)90.59%
  • Net Margin (MRQ)-1,026.35%
  • Debt To Equity (MRQ)-1,424.84%

EVENTS

  • Earnings Date05/04/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest BioCryst Pharmaceuticals Inc News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
BioCryst Pharmaceuticals, Inc. is a biotechnology company. The Company designs, optimizes and develops small molecule drugs that block enzymes involved in the pathogenesis of diseases. The Company focuses on the treatment of rare diseases. It uses X-ray crystallography, computer modeling of molecular structures and chemistry techniques to focus on the three-dimensional molecular structure and active site characteristics of the enzymes that control cellular biology. The...
Robert Ingram
Chairman
Jon Stonehouse
Chief Executive Officer
Anthony Doyle
Chief Financial Officer
Michael Jones CPA
Chief Accounting Officer
Allen Hodge
Vice President
Address
4505 Emperor Blvd Ste 200
Durham, NC
27703-8457
United States